Inflammatory signalling as mediator of epigenetic modulation in tissue-specific chronic inflammation

被引:94
作者
Baeckdahl, Liselotte [1 ]
Bushell, Andrew [2 ]
Beck, Stephan [1 ]
机构
[1] UCL, Inst Canc, Med Genom Grp, London WC1E 6BT, England
[2] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Transplantat Res Immunol Grp, Oxford OX3 9DU, England
关键词
Epigenetics; Chronic inflammation; Epigenetic regulation; T cells; Inflammatory diseases; NF-KAPPA-B; HISTONE DEACETYLASE INHIBITOR; ABERRANT DNA METHYLATION; LUPUS-LIKE DISEASE; T-CELL ACTIVATION; EXPERIMENTAL COLITIS; MULTIPLE-SCLEROSIS; GENE-EXPRESSION; CUTTING EDGE; TRANSCRIPTION;
D O I
10.1016/j.biocel.2008.08.023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent Successes of therapeutic intervention in chronic inflammatory diseases using epigenetic modifiers Such as historic deacetylase inhibitors and inhibitors of DNA methylation Suggest that epigenetic reprogramming plays a role in the aetiology of these diseases. The epigenetic signature of a given immune cell is reflected in the history of modifications from different signals the cell has been subjected to during differentiation. Like other cells, differentiating immune cells are dependent on a complex combination of inter- and intracell signalling as well as transcription machineries to modulate their epigenomes ill order to mediate differentiation. Despite extensive research into these processes, the link between cellular signalling and epigenetic modulation remains poorly understood. Here, we review recent progress and discuss key factors driving epigenetic modulation in chronic inflammation. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:176 / 184
页数:9
相关论文
共 112 条
[1]   Role of redox potential and reactive oxygen species in stress signaling [J].
Adler, V ;
Yin, ZM ;
Tew, KD ;
Ronai, Z .
ONCOGENE, 1999, 18 (45) :6104-6111
[2]  
Ahuja N, 2000, HISTOL HISTOPATHOL, V15, P835, DOI 10.14670/HH-15.835
[3]   Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation [J].
Akimzhanov, Askar M. ;
Yang, Xuexian O. ;
Dong, Chen .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (09) :5969-5972
[4]   Regulation of Th2 differentiation and Il4 locus accessibility [J].
Ansel, K. Mark ;
Djuretic, Ivana ;
Tanasa, Bogdan ;
Rao, Anjana .
ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 :607-656
[5]   High-resolution profiling of histone methylations in the human genome [J].
Barski, Artern ;
Cuddapah, Suresh ;
Cui, Kairong ;
Roh, Tae-Young ;
Schones, Dustin E. ;
Wang, Zhibin ;
Wei, Gang ;
Chepelev, Iouri ;
Zhao, Keji .
CELL, 2007, 129 (04) :823-837
[6]   The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 [J].
Bennett, CL ;
Christie, J ;
Ramsdell, F ;
Brunkow, ME ;
Ferguson, PJ ;
Whitesell, L ;
Kelly, TE ;
Saulsbury, FT ;
Chance, PF ;
Ochs, HD .
NATURE GENETICS, 2001, 27 (01) :20-21
[7]   Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells [J].
Bettelli, E ;
Dastrange, M ;
Oukka, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (14) :5138-5143
[8]   Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis [J].
Bettelli, E ;
Sullivan, B ;
Szabo, SJ ;
Sobel, RA ;
Glimcher, H ;
Kuchroo, VK .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (01) :79-87
[9]   Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases? [J].
Blanchard, F ;
Chipoy, C .
DRUG DISCOVERY TODAY, 2005, 10 (03) :197-204
[10]   Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse [J].
Brunkow, ME ;
Jeffery, EW ;
Hjerrild, KA ;
Paeper, B ;
Clark, LB ;
Yasayko, SA ;
Wilkinson, JE ;
Galas, D ;
Ziegler, SF ;
Ramsdell, F .
NATURE GENETICS, 2001, 27 (01) :68-73